Green fluorescent protein-adenoviral construct as a model for transient gene therapy for human cultured keratinocytes in an athymic mouse model

Journal of Trauma

Volumn 54, Issue 1, 2003, Pages 72-80

  Campbell, Chris ^a   Hultman, Scott ^a   Cairns, Bruce ^a   Deserres, Suzan ^a   Meyer, Anthony ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Adenovirus; Burns; Cultured keratinocytes; Gene therapy; Green fluorescent protein; Skin graft

Indexed keywords

ADENOVIRUS VECTOR; GREEN FLUORESCENT PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS DNA;

ANIMAL MODEL; ANIMAL TISSUE; BURN; CELL CULTURE; CELL TRANSPLANTATION; CONFERENCE PAPER; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MOUSE; NONHUMAN; NUDE MOUSE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN GRAFT; VIRAL GENE DELIVERY SYSTEM; WOUND HEALING;

ADENOVIRIDAE; ANIMALS; BIOPSY; BURNS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; DNA, VIRAL; GENE EXPRESSION; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INDICATORS AND REAGENTS; KERATINOCYTES; LUMINESCENT PROTEINS; MICE; MICE, NUDE; MICROSCOPY, FLUORESCENCE; MODELS, ANIMAL; POLYMERASE CHAIN REACTION; SKIN, ARTIFICIAL; TRANSFECTION; WOUND HEALING;

EID: 0037237212     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005373-200301000-00010     Document Type: Article

References (35)

1. Rue LW III, Cioffi WG, McManus WF, Pruitt BA Jr. Wound closure and outcome in extensively burned patients treated with cultured autologous keratinocytes. J Trauma. 1993; 34: 662-667.
2. Munster AM, Weiner SH, Spence RJ. Cultured epidermis for the coverage of massive burn wounds. Ann Surg. 1990; 211: 676-679.
3. Herzog SR, Meyer A, Woodley D, Peterson HD. Wound coverage with cultured autologous keratinocytes: use after burn wound excision, including biopsy follow-up. J Trauma. 1988; 28: 195-198.
4. O'Connor NE, Mulliken JB, Banks-Schlegel S, Kehinde O, Green H. Grafting of burns with cultured epithelium prepared from autologous epidermal cells. Lancet. 1981; 1: 75-78.
5. Gallico GG, O'Connor NE, Compton CC, Kehinde O, Green H. Permanent coverage of large burn wounds with autologous cultured human epithelium. N Engl J Med. 1984; 311: 448-451.
6. Boyce ST, Goretsky MJ, Greenhalgh DG, Kagan RJ, Rieman MT, Warden GD. Comparative assessment of cultured skin substitutes and native skin autograft for treatment of full-thickness burns. Ann Surg. 1995; 222: 743-752.
7. Boyce ST, Kagan RJ, Yakuboff KP, et al. Cultured skin substitutes reduce donor skin harvesting for closure of excised, full-thickness burns. Ann Surg. 2002; 235: 269-279.
8. Eming SA, Snow RG, Yarmush ML, Morgan JR. Targeted expression of insulin-like growth factor to human keratinocytes: modifications of the autocrine control of keratinocyte proliferation. J Invest Dermatol. 1996; 107: 113-120.
9. Morgan JR, Barrandon Y, Green H, Mulligan RC. Expression of an exogenous growth hormone gene by transplantable human epidermal cells. Science 1987 237 1476-1479.
10. Vogt PM, Thompson S, Andree C, et al. Genetically modified keratinocytes transplanted to wounds reconstitute the epidermis. Proc Natl Acad Sci USA. 1994; 91: 9307-9311.
11. Supp DM, Supp AP, Bell SM, Boyce ST. Enhanced vascularization of cultured skin substitutes genetically modified to overexpress endothelial growth factor. J Invest Dermatol. 2000; 114: 5-13.
12. Supp DM, Bell SM, Morgan JR, Boyce ST. Genetic modification of cultured skin substitutes by transduction of human keratinocytes and fibroblasts with platelet-derived growth factor-A. Wound Repair Regen. 2000; 8: 26-35.
13. Andreadis ST, Hamoen KE, Yarmush ML, Morgan JR. Keratinocyte growth factor induces hyperproliferation and delays differentiation in a skin equivalent model system. FASEB J. 2001; 15: 898-906.
14. Hansbrough JF, Zapata-Sirvent R, Peterson V, et al. Characterization of the immunosuppressive effect of burned tissue in an animal model. J Surg Res. 1984; 37: 383-393.
15. Weiss RA. Retroviral zoonoses. Nat Med. 1998; 4: 391-392.
16. Gunzburg WH, Salmons B. Development of retroviral vectors as safe, targeted gene delivery systems. J Mol Med. 1996; 74: 171-182.
17. Wood EJ, Harris IR. Reconstructed human skin: transplant, graft, or biological dressing? Essays Biochem. 1995; 29: 65-85.
18. Chrombleholme T. Adenoviral-mediated gene transfer in wound healing. Wound Repair Regen. 2000; 8: 460-472.
19. Kozarsky K. Gene therapy: adenovirus vectors. Curr Opin Genet Dev. 1993; 3: 499-503.
20. Bett A. Packaging capacity and stability of human adenovirus type 5 vectors. J Virol. 1993; 67: 5911-5921.
21. Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell. 1975; 6: 331-343.
22. Boyce ST, Harriger D, Supp AP, Warden GD, Holder IA. Effective management of microbial contamination in cultured skin substitutes after grafting to athymic mice. Wound Repair Regen. 1997; 5: 191-197.
23. Kim HS, Lee G, John SWM, Maeda N, Smithies O. Molecular phenotyping for analyzing subtle genetic effects in mice: application to an angiotensinogen gene titration. Proc Natl Acad Sci USA. 2002; 99: 4602-4607.
24. Ghazizadeh S, Taichman LB. Virus-mediated gene transfer for cutaneous gene therapy. Hum Gene Ther. 2000; 11: 2247-2251.
25. Benihoud K, Yeh P, Perricaudet M. Adenovirus vectors for gene delivery. Curr Opin Biotechnol. 1999; 10: 440-447.
26. Martin P. Wound healing: aiming for perfect skin regeneration. Science. 1997; 276: 75-81.
27. Tepper OM, Mehrara BJ. Gene therapy in plastic surgery. Plast Reconstr Surg. 2002; 109: 716-734.
28. Worgall S. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum Gene Ther. 1997; 8: 37-44.
29. Parks R. Improvements in adenoviral technology: overcoming barriers for gene therapy. Clin Genet. 2000; 58: 1-11.
30. Morsy M. An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene. Proc Natl Acad Sci USA. 1998; 95: 7866-7871.
31. Scheidner G. Genomic DNA transfer with a high capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat Genet. 1998; 18: 180-183.
32. Tsien RY. The green fluorescent protein. Ann Rev Biochem. 1998; 67: 509-544.
33. Schaefer BM, Wallich R, Schmolke K, et al. Immunohistochemical and molecular characterization of cultured keratinocytes after dispase-mediated detachment from the growth substratum. Exp Dermatol. 2000; 9: 58-64.
34. Poumay Y, Boucher F, Leclercq-Smekens M, Degen A, Leloup R. Basal cell adhesion to a culture substratum controls the polarized spatial organization of human epidermal keratinocytes into proliferating basal and terminally differentiating suprabasal populations. Epithelial Cell Biol. 1993; 2: 7-16.
35. Fenjves ES, Yao SN, Kurachi K, Taichman LB. Loss of expression of a retrovirus-transduced gene in human keratinocytes. J Invest Dermatol. 1996; 106: 576-578.